Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.

If you miss the grocery store you grew up with, you're probably not alone. Many popular and once-dominant chains have folded ...

Robinhood Markets' stock surge prompts reassessment ahead of Q4 earnings. Click here to find out why HOOD stock is a Strong ...

Though antioxidants are good for your health, taking them in supplement form is often unnecessary and can pose risks. Here's ...

U.S. retirement plans in Pensions & Investments ’ latest annual survey reported their strongest gains in three years, even as ...

Are you slay? Not if you don’t know this Gen Alpha lingo. From “mewing” and “slaying” to “sigma” and “rizz,” youngsters’ ...

Semiconductor (AOS), currently valued at $1.24 billion, reported its Q2 fiscal 2025 earnings, missing Wall Street expectations significantly. The company posted earnings per share (EPS) of $0.09, ...

LTD., a subsidiary of GRAVITY Co., Ltd. (NasdaqGM: GRVY) is making a major comeback with the Closed Beta Test (CBT) for the legendary artillery ... and also compatibility issues encountered during the ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...

From “mewing” and “slaying” to “sigma” and “rizz,” the lingo of Gen Alpha is baffling parents more than ever before. “When we ...

JPMorgan Chase & Co. lifted its holdings in Janus Henderson Small/Mid Cap Growth Alpha ETF (NASDAQ:JSMD – Free Report) by 432.6% during the third quarter, according to its most recent 13F filing with ...

The Monster Hunter Wilds beta starts on Thursday, February 6, 2025 and runs through until Sunday, February 9, 2025. This is ...